B. Riley Weighs in on Aspen Aerogels FY2024 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN) – Research analysts at B. Riley issued their FY2024 earnings per share (EPS) estimates for shares of Aspen Aerogels in a note issued to investors on Monday, January 6th. B. Riley analyst R. Pfingst expects that the construction company will earn $0.16 per share for the year. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. B. Riley also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.14 EPS, Q1 2025 earnings at $0.09 EPS, Q2 2025 earnings at $0.12 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.18 EPS, FY2025 earnings at $0.54 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $1.33 EPS.

A number of other equities analysts have also issued reports on ASPN. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday, November 13th. HC Wainwright restated a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. Roth Mkm lowered their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Barclays reduced their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. Finally, Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Aspen Aerogels has a consensus rating of “Moderate Buy” and an average price target of $30.00.

Aspen Aerogels Stock Performance

Shares of NYSE ASPN opened at $13.18 on Thursday. Aspen Aerogels has a 12 month low of $10.75 and a 12 month high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.08 billion, a P/E ratio of 1,319.32 and a beta of 2.14. The business’s 50 day moving average is $14.15 and its two-hundred day moving average is $20.78.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently modified their holdings of the company. Lord Abbett & CO. LLC bought a new stake in shares of Aspen Aerogels during the third quarter worth $10,126,000. Franklin Resources Inc. grew its holdings in Aspen Aerogels by 5.3% during the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock worth $815,000 after acquiring an additional 1,483 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Aspen Aerogels in the third quarter worth about $498,000. Geode Capital Management LLC lifted its position in shares of Aspen Aerogels by 5.7% during the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after purchasing an additional 75,024 shares in the last quarter. Finally, Barclays PLC grew its stake in shares of Aspen Aerogels by 333.8% during the third quarter. Barclays PLC now owns 92,302 shares of the construction company’s stock valued at $2,557,000 after purchasing an additional 71,024 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.